{
    "nct_id": "NCT05830838",
    "official_title": "Daily Adaptive Post-Prostatectomy Radiation With Stereotactic Ablative Radiotherapy (DAPPER)",
    "inclusion_criteria": "* Males age >= 18 years who are receiving post-operative radiation therapy to the prostate fossa, with or without inclusion of the pelvic lymph nodes, for biochemical recurrences after radical prostatectomy.\n* Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) =< 2.\n* Ability to complete questionnaire(s) by themselves or with assistance.\n* Provide written informed consent.\n* Willingness and ability to complete protocol-specified follow-up (during the active monitoring phase of the study).\nHealthy volunteers allowed\nMust be MALE\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Current evidence of untreated metastatic prostate cancer involving nonregional lymph nodes outside of the bony pelvis, bone, or visceral organs.\n* Receipt of cytotoxic chemotherapy within 3 months prior to enrollment.\n* Prior radiation therapy to pelvis such that the proposed study treatment volume received 10 Gy or greater.\n* Co-morbid severe concurrent disease that would result in a life expectancy of < 5 years.\n* Diabetes mellitus-associated vascular ulcers or wounding healing problems, inflammatory bowel disease, or a diagnosed connective tissue disorder.\n* Medical or psychiatric conditions that preclude informed decision-making or adherence to study protocols.\n* Men of childbearing potential who are unwilling to employ adequate contraception.\n* History of a bladder neck contracture, urethral stricture that required dilation, or any surgical repair/reconstruction involving the bladder or urethra other than radical prostatectomy.",
    "miscellaneous_criteria": ""
}